[1]
S. JACOB BUNU, D. ERE, and O. MIEDIEGHA, “CLINICAL RELEVANCE OF EFAVIRENZ PHARMACOKINETICS AND PHARMACOGENETICS IN HIV/AIDS THERAPY”, Asian J Pharm Clin Res, vol. 13, no. 6, pp. 26–30, Jun. 2020.